Cenova Ventures
Carlyle-backed Adicon trades up after $52m Hong Kong IPO
Adicon Holdings, a China-based independent clinical laboratory (ICL) services provider backed by The Carlyle Group, gained 12% on debut following a HKD 408.9m (USD 52.2m) Hong Kong IPO.
Cenova leads $40m Series B for China's Eluminex
China-based healthcare investor Cenova Capital has led a USD 40m Series B round for Eluminex Biosciences, which is developing drugs and regenerative tissue used to treat eye disease and other vision-threatening medical conditions.
China's BangEr Orthopedic raises $46m
Chinese hospital chain operator BangEr Orthopedic has raised a RMB300 million ($46 million) Series D round led by Fortune Capital and Cenova Capital.
China healthtech player gets $100m Series C extension
Weimai, a Chinese healthcare-focused big data platform that primarily serves hospitals and clinics in lower-tier cities, has raised $100 million in an extended Series C round led by Baidu Capital.
Cenova leads $37m round for China's Nanyan Insurtech
Chinese insurance platform Nanyan Insurtech has raised a RMB250 million ($37 million) Series C round led by Cenova Ventures. SIG China and BlueRun Ventures both re-upped.
ByteDance acquires Chinese medical platform for $72m
ByteDance, the PE-backed owner of TikTok and the Toutiao news aggregation service, has acquired VC-backed Chinese medical information platform Baikemy for RMB500 million ($72 million).
Deal focus: Weimai seeks healthcare monetization
Weimai plans to leverage a fresh $100 million funding round to bring new technologies to Chinese hospitals. This will include a growing focus on services outside the public health system
IDG leads $100m round for China healthcare platform Weimai
IDG Capital has led a $100 million funding round for Weimai, a Chinese healthcare-focused big data platform that helps hospitals and clinics in lower-tier cities automate everything from appointment registration to medical records management.
China healthcare big data platform gets $30m Series B
Weimai, a Chinese healthcare-focused big data platform that operates on a city-by-city basis, has received $30 million in Series B funding led by Cenova Ventures, Source Code Capital, Vision Plus Capital, and Matrix Partners China.
Singapore's Aslan Pharma raises $42m in US IPO
Aslan Pharmaceutical, a Singapore-based drug developer that focuses on cancer treatments, has raised $42.2 million in its US IPO. The VC-backed company listed on the Taiwan Stock Exchange last June.